Clinical trial · Observational
Prostate Cancer Prospective Cohort
NCT00937586CI-TRIAL-00099085active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overall purpose of this research is to determine if certain genes increase the chance of developing prostate cancer and once diagnosed increase the chance of the prostate cancer spreading to other parts of the body.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Newly diagnosed patients
- description
- Patients with newly diagnosed prostate cancer.
Primary outcomes (1)
- measure
- Ability to recognize increased risk of metastatic prostate cancer based on specific genetic polymorphisms.
- timeFrame
- At the time of prostate cancer diagnosis
Secondary outcomes (1)
- measure
- Ability to predict risk for treatment failure based on analysis of specific polymorphisms.
- timeFrame
- At the time of prostate cancer diagnosis
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Newly diagnosed patients: 1. newly diagnosis of prostate cancer 2. untreated except for neoadjuvant systemic therapy. Exclusion Criteria: * Newly diagnosed patients: 1. inability to give informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.